- 3-MXP
- 3-Methoxydiphenidine
Wallach, J; Kang, H; Colestock, T; Morris, H; Bortolotto, ZA; Collingridge, GL; Lodge, D; Halberstadt, AL; Brandt, SD; Adejare, A. Pharmacological investigations of the dissociative “Legal Highs” diphenidine, methoxphenidine and analogues PLOS ONE, 17 Jun 2016, 11 (6), e0157021. 8.9 MB. https://doi.org/10.1371/journal.pone.0157021 #3-MXP GC,MS,NMR
McLaughlin, G; Morris, N; Kavanagh, PV; Power, JD; O’Brien, J; Talbot, B; Elliott, SP; Wallach, J; Hoang, K; Morris, H; Brandt, SD. Test purchase, synthesis, and characterization of 2-methoxydiphenidine (MXP) and differentiation from its meta- and para-substituted isomers Drug Test. Anal., 1 Jan 2016, 8 (1), 98-109. 1.2 MB. https://doi.org/10.1002/dta.1800 #3-MXP GC,LC,MS,NMR,TLC
Wallach, J; Brandt, SD. 1,2-Diarylethylamine- and ketamine-based new psychoactive substances In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 305-352. 593 kB. https://doi.org/10.1007/164_2018_148 #3-MXP